2023


  1. Uttinger KL, Brunotte M, Diers J, Lock JF, Jansen-Winkeln B, Seehofer D, Germer CT, Wiegering A (2023). Diverticulitis patient care during the Covid-19 pandemic in Germany-a retrospective nationwide population-based cohort study. Langenbecks Arch Surg, 408(1), 447.
     
  2. Seidemann L, Prinz S, Scherbel JC, Götz C, Seehofer D, Damm G (2023). Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-Matrigel matrices. EXCLI J, 22(), 12-34.
     
  3. Uttinger KL, Brunotte M, Diers J, Lock JF, Jansen-Winkeln B, Seehofer D, Germer CT, Wiegering A (2023). Diverticulitis patient care during the Covid-19 pandemic in Germany-a retrospective nationwide population-based cohort study. Langenbecks Arch Surg, 408(1), 447-.
     
  4. Rademacher S, Brunotte M, Wichmann Y, Mehdorn M, Kaths JM, Seehofer D, Sucher R, Scheuermann U (2023). Effect of Pre-Transplant Recipient Underweight on the Postoperative Outcome and Graft Survival in Primary Kidney Transplantation. Transplant Proc, 55(7), 1521-1529.
     
  5. Recknagel S, Rademacher S, Höhne C, Lederer AA, Lange UG, Herta T, Seehofer D, Sucher R, Scheuermann U (2023). Prediction of the Postoperative Outcome in Liver Resection Using Perioperative Serum Lactate Levels. J Clin Med, 12(6), 2100-.
     
  6. Krause A, Stocker G, Gockel I, Seehofer D, Hoffmeister A, Bläker H, Denecke T, Kluge R, Lordick F, Knödler M (2023). Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer. J Cancer Res Clin Oncol, 149(3), 1231-1240.
     
  7. Proß V, Sattler A, Lukassen S, Tóth L, Thole LML, Siegle J, Stahl C, He A, Damm G, Seehofer D, Götz C, Bayerl C, Jäger P, Macke A, Eggeling S, Kirzinger B, Mayr T, Herbst H, Beyer K, Laue D, Krönke J, Braune J, Rosseck F, Kittner B, Friedersdorff F, Hubatsch M, Weinberger S, Lachmann N, Hofmann VM, Schrezenmeier E, Ludwig C, Schrezenmeier H, Jechow K, Conrad C, Kotsch K (2023). SARS-CoV-2 mRNA vaccination-induced immunological memory in human nonlymphoid and lymphoid tissues. J Clin Invest, 133(24), 171797.
     
  8. Ehrengut C, Vogt J, Leonhardi J, Carabenciov E, Teske F, Boemmel FV, Berg T, Seehofer D, Lincke T, Sabri O, Gößmann H, Denecke T, Ebel S (2023). Analysis of Periprocedural X-ray Exposure in Transarterial Radioembolization with Glass or Resin Microspheres. Diagnostics (Basel), 13(24), 3609-.
     
  9. Leonhardi J, Sabanov A, Schnarkowski B, Hoehn AK, Sucher R, Seehofer D, Denecke T, Meyer HJ (2023). CT Texture Analysis and Node-RADS CT Score of Lymph Nodes in Patients With Perihilar Cholangiocarcinoma. Anticancer Res, 43(11), 5089-5097.
     
  10. Weimann A, Ahlert M, Seehofer D, Zieschang T, Schweda M (2023). Old Age and Frailty in Deceased Organ Transplantation and Allocation-A Plea for Geriatric Assessment and Prehabilitation. Transpl Int, 36(), 11296-.
     
  11. Walter Costa MB, Gärtner C, Schmidt M, Berg T, Seehofer D, Kaiser T (2023). Revising the MELD Score to Address Sex-Bias in Liver Transplant Prioritization for a German Cohort. J Pers Med, 13(6), 963-.
     
  12. Bitzer M, Groß S, Albert J, Boda-Heggemann J, Brunner T, Caspari R, De Toni E, Dombrowski F, Evert M, Geier A, Gkika E, Götz M, Helmberger T, Hoffmann RT, Huppert P, Kautz A, Krug D, Fougère C, Lang H, Lenz P, Lüdde T, Mahnken A, Nadalin S, Nguyen HHP, Ockenga J, Oldhafer K, Paprottka P, Pereira P, Persigehl T, Plentz R, Pohl J, Recken H, Reimer P, Riemer J, Ritterbusch U, Roeb E, Rüssel J, Schellhaas B, Schirmacher P, Schlitt HJ, Schmid I, Schuler A, Seehofer D, Sinn M, Stengel A, Stoll C, Tann (2023). S3-Leitlinie Diagnostik und Therapie biliärer Karzinome. Z Gastroenterol, 61(4), 420-440.
     
  13. Bitzer M, Groß S, Albert J, Boda-Heggemann J, Brunner T, Caspari R, De Toni E, Dombrowski F, Evert M, Geier A, Gkika E, Götz M, Helmberger T, Hoffmann RT, Huppert P, Kautz A, Krug D, Fougère C, Lang H, Lenz P, Lüdde T, Mahnken A, Nadalin S, Nguyen HHP, Ockenga J, Oldhafer K, Paprottka P, Pereira P, Persigehl T, Plentz R, Pohl J, Recken H, Reimer P, Riemer J, Ritterbusch U, Roeb E, Rüssel J, Schellhaas B, Schirmacher P, Schlitt HJ, Schmid I, Schuler A, Seehofer D, Sinn M, Stengel A, Stoll C, Tann (2023). S3-Leitlinie Diagnostik und Therapie biliärer Karzinome ? Langversion. Z Gastroenterol, 61(4), 92-156.
     
  14. Lieb S, Ebel S, Seehofer D, Berg T, van Bömmel F (2023). The CRAFITY score can identify patients with hepatocellular carcinoma showing poor response to treatment with atezolizumab and bevacizumab. Hepatobiliary Surg Nutr, 12(1), 148-150.
     


    15. 2022


  15. Schicht G, Seidemann L, Haensel R, Seehofer D, Damm G (2022). Critical Investigation of the Usability of Hepatoma Cell Lines HepG2 and Huh7 as Models for the Metabolic Representation of Resectable Hepatocellular Carcinoma. Cancers (Basel), 14(17), 4227.
     
  16. Scheffschick A, Babel J, Sperling S, Nerusch J, Herzog N, Seehofer D, Damm G (2022). Primary-like Human Hepatocytes Genetically Engineered to Obtain Proliferation Competence as a Capable Application for Energy Metabolism Experiments in In Vitro Oncologic Liver Models. Biology (Basel), 11(8), 1195.
     
  17. Rademacher S, Denecke T, Berg T, Seehofer D (2022). [Cholangiocarcinoma-Intrahepatic to hilar bile duct cancer]. Chirurgie (Heidelb), 93(7), 644-651.
     
  18. Jahn N, Völker MT, Laudi S, Stehr S, Schneeberger S, Brandacher G, Sucher E, Rademacher S, Seehofer D, Hau HM, Sucher R (2022). Analysis of Volatile Anesthetic-Induced Organ Protection in Simultaneous Pancreas-Kidney Transplantation. J Clin Med, 11(12), 3385.
     
  19. Seehofer D, Petrowsky H, Schneeberger S, Vibert E, Ricke J, Sapisochin G, Nault JC, Berg T (2022). Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation-Adjusting the Odds? Transpl Int, 35(), 10333.
     
  20. Sucher R, Schiemanck T, Hau HM, Laudi S, Stehr S, Sucher E, Rademacher S, Seehofer D, Jahn N (2022). Influence of Intraoperative Hemodynamic Parameters on Outcome in Simultaneous Pancreas-Kidney Transplant Recipients. J Clin Med, 11(7), 1966.
     
  21. Sucher R, Scheuermann U, Rademacher S, Lederer A, Sucher E, Hau HM, Brandacher G, Schneeberger S, Gockel I, Seehofer D (2022). Intraoperative reperfusion assessment of human pancreas allografts using hyperspectral imaging (HSI). Hepatobiliary Surg Nutr, 11(1), 67-77.
     
  22. Seehofer D, Sucher R, Denecke T (2022). [Resection and transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma]. Radiologe, 62(3), 210-218.
     
  23. Scheuermann U, Babel J, Pietsch UC, Weimann A, Lyros O, Semmling K, Hau HM, Seehofer D, Rademacher S, Sucher R (2022). Recipient obesity as a risk factor in kidney transplantation. BMC Nephrol, 23(1), 37.
     
  24. Sucher R, Wagner T, Köhler H, Sucher E, Quice H, Recknagel S, Lederer A, Hau HM, Rademacher S, Schneeberger S, Brandacher G, Qockel I, Seehofer D (2022). Hyperspectral Imaging (HSI) of Human Kidney Allografts. Ann Surg, 276(1), e48-e55.
     
  25. Jahn N, Voelker MT, Laudi S, Stehr S, Schneeberger S, Brandacher G, Sucher E, Rademacher S, Seehofer D, Sucher R, Hau HM (2022). Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation. J Clin Med, 11(9), 2563.
     
  26. Heinke P, Rost F, Rode J, Trus P, Simonova I, Lázár E, Feddema J, Welsch T, Alkass K, Salehpour M, Zimmermann A, Seehofer D, Possnert G, Damm G, Druid H, Brusch L, Bergmann O (2022). Diploid hepatocytes drive physiological liver renewal in adult humans. Cell Syst, 13(6), 499-507.
     
  27. Brecklinghaus T, Albrecht W, Duda J, Kappenberg F, Gründler L, Edlund K, Marchan R, Ghallab A, Cadenas C, Rieck A, Vartak N, Tolosa L, Castell JV, Gardner I, Halilbasic E, Trauner M, Ullrich A, Zeigerer A, Demirci Turgunbayer Ö, Damm G, Seehofer D, Rahnenführer J, Hengstler JG (2022). In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay. Toxicol Lett, 368(), 33-46.
     
  28. Schmelzle M, Benzing C, Fischer L, Herden U, Sterneck M, Settmacher U, Bauschke A, Neumann U, Pelzer U, Müller T, Strassburg C, Lang H, Becker T, Königsrainer A, Nadalin S, Quante M, Paul A, Friess H, Klempnauer J, Richter N, Vondran F, Pascher A, Rösch T, Schöning W, Krenzien F, Öllinger R, Seehofer D, Neuhaus P, Pratschke J (2022). Feasibility and Efficacy of Adjuvant Chemotherapy With Gemcitabine After Liver Transplantation for Perihilar Cholangiocarcinoma - A Multi-Center, Randomized, Controlled Trial (pro-duct001). Front Oncol, 12(), 910871.
     
  29. Jahn N, Sack U, Stehr S, Vöelker MT, Laudi S, Seehofer D, Atay S, Zgoura P, Viebahn R, Boldt A, Hau HM (2022). The Role of Innate Immune Cells in the Prediction of Early Renal Allograft Injury Following Kidney Transplantation. J Clin Med, 11(20), 6148.
     
  30. Olbrich A, Gros O, Ebel S, Denecke T, Gößmann H, Linder N, Lordick F, Forstmeyer D, Seehofer D, Sucher R, Rademacher S, Niemeyer J, Matz-Soja M, Berg T, Bömmel FV (2022). Dickkopf-Related Protein 1 as Response Marker for Transarterial Chemoembolization of Hepatocellular Carcinomas. Cancers (Basel), 14(19), 4807.
     
  31. Grinberg M, Stöber RM, Edlund K, Rempel E, Godoy P, Reif R, Widera A, Madjar K, Schmidt-Heck W, Marchan R, Sachinidis A, Spitkovsky D, Hescheler J, Carmo H, Arbo MD, van de Water B, Wink S, Vinken M, Rogiers V, Escher S, Hardy B, Mitic D, Apic G, Myatt G, Waldmann T, Mardinoglu A, Damm G, Seehofer D, Nüssler A, Weiss TS, Oberemm A, Lampen A, Schaap MM, Luijten M, van Steeg H, Thasler WE, Kleinjans JCS, Stierum RH, Leist M, Rahnenführer J, Hengstler JG (2022). Correction to: Toxicogenomics directory of chemically exposed human hepatocytes. Arch Toxicol, 96(3), 945-946.
     
  32. Hau HM, Eckert M, Laudi S, Völker MT, Stehr S, Rademacher S, Seehofer D, Sucher R, Piegeler T, Jahn N (2022). Predictive Value of HAS-BLED Score Regarding Bleeding Events and Graft Survival following Renal Transplantation. J Clin Med, 11(14), 4025.
     
  33. Jahn N, Voelker MT, Laudi S, Stehr S, Schneeberger S, Brandacher G, Sucher E, Rademacher S, Seehofer D, Sucher R, Hau HM (2022). Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation. J Clin Med, 11(9), 2563.
     
  34. Engelmann C, Aehling NF, Schob S, Nonnenmacher I, Handmann L, Macnaughtan J, Herber A, Surov A, Kaiser T, Denecke T, Jalan R, Seehofer D, Moche M, Berg T (2022). Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosis. Hepatol Commun, 6(8), 2198-2209.
     
  35. Fodor M, Zoller H, Oberhuber R, Sucher R, Seehofer D, Cillo U, Line PD, Tilg H, Schneeberger S (2022). The Need to Update Endpoints and Outcome Analysis in the Rapidly Changing Field of Liver Transplantation. Transplantation, 106(5), 938-949.
     
  36. Pfrepper C, Knödler M, Schorling RM, Seehofer D, Petros S, Lordick F (2022). Predictors for thromboembolism in patients with cholangiocarcinoma. J Cancer Res Clin Oncol, 148(9), 2415-2426.
     
  37. Veelken R, Maiwald B, Strocka S, Petersen TO, Moche M, Ebel S, Denecke T, Rehak M, Struck MF, Forstmeyer D, Rademacher S, Seehofer D, Berg T, van Bömmel F (2022). Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers. Cardiovasc Intervent Radiol, 45(2), 218-222.
     


    38. 2021


  38. Moulla Y, Buchloh DC, Köhler H, Rademacher S, Denecke T, Meyer HJ, Mehdorn M, Lange UG, Sucher R, Seehofer D, Jansen-Winkeln B, Gockel I (2021). Hyperspectral Imaging (HSI)-A New Tool to Estimate the Perfusion of Upper Abdominal Organs during Pancreatoduodenectomy. Cancers (Basel), 13(11), 2846.
     
  39. Hau HM, Devantier M, Jahn N, Sucher E, Rademacher S, Seehofer D, Sucher R (2021). Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA). Cancers (Basel), 13(19), 4772.
     
  40. Hau HM, Jahn N, Rademacher S, Sucher E, Babel J, Mehdorn M, Lederer A, Seehofer D, Scheuermann U, Sucher R (2021). The Value of Graft Implantation Sequence in Simultaneous Pancreas-Kidney Transplantation on the Outcome and Graft Survival. J Clin Med, 10(8), 1632.
     
  41. Seidemann L, Krüger A, Kegel-Hübner V, Seehofer D, Damm G (2021). Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis. Molecules, 26(4), 1156.
     
  42. Hau HM, Jahn N, Brunotte M, Wagner T, Rademacher S, Branzan D, Sucher E, Seehofer D, Sucher R (2021). Pre-operative ankle-brachial index for cardiovascular risk assessment in simultaneous pancreas-kidney transplant recipients: a simple and elegant strategy! BMC Surg, 21(1), 156.
     
  43. Zimmermann A, Hänsel R, Gemünden K, Kegel-Hübner V, Babel J, Bläker H, Matz-Soja M, Seehofer D, Damm G (2021). In Vivo and In Vitro Characterization of Primary Human Liver Macrophages and Their Inflammatory State. Biomedicines, 9(4), 406.
     
  44. Scheuermann U, Rademacher S, Wagner T, Lederer A, Hau HM, Seehofer D, Sucher R (2021). Influence of Multiple Donor Renal Arteries on the Outcome and Graft Survival in Deceased Donor Kidney Transplantation. J Clin Med, 10(19), 4395.
     
  45. Lange UG, Rademacher S, Zirnstein B, Sucher R, Semmling K, Bobbert P, Lederer AA, Buchloh D, Seidemann L, Seehofer D, Jahn N, Hau HM (2021). Cardiovascular outcomes after simultaneous pancreas kidney transplantation compared to kidney transplantation alone: a propensity score matching analysis. BMC Nephrol, 22(1), 347.
     
  46. Rademacher S, Aehling NF, Sucher R, Berg T, Seehofer D (2021). Current State and Future Possibilities in Liver Transplantation. Surg Technol Int, 39(), 128-134.
     
  47. Seehofer D, Corradini S, Sucher R, Ricke J (2021). Multimodale Therapie des Cholangiokarzinoms Verdauungskrankheiten, 39(3), 148-157.
     
  48. Babel J, Rademacher S, Denecke T, Seehofer D (2021). Zystische Leberläsionen ? Diagnostik und Therapieoptionen Allgemein- und Viszeralchirurgie up2date, 15(5), 407-424.
     
  49. Bielow T, Blank V, Opitz S, Gößmann H, Hecker M, Seehofer D, Lübbert C, Karlas T (2021). Klebsiella Pneumoniae Liver Abscess Syndrome - A Challenge for Contrast-Enhanced Ultrasound. Ultrasound Int Open, 7(1), 2-5.
     
  50. Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, Wree A, Damm G, Seehofer D, Calvente CJ, Povero D, Kisseleva T, Eguchi A, McGeough MD, Hoffman HM, Pelegrin P, Laufs U, Feldstein AE (2021). Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol, 74(1), 156-167.
     
  51. Gianmoena K, Gasparoni N, Jashari A, Gabrys P, Grgas K, Ghallab A, Nordström K, Gasparoni G, Reinders J, Edlund K, Godoy P, Schriewer A, Hayen H, Hudert CA, Damm G, Seehofer D, Weiss TS, Boor P, Anders HJ, Motrapu M, Jansen P, Schiergens TS, Falk-Paulsen M, Rosenstiel P, Lisowski C, Salido E, Marchan R, Walter J, Hengstler JG, Cadenas C (2021). Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria. Cell Rep, 36(8), 109526.
     
  52. Hunold P, Berg T, Seehofer D, Sucher R, Herber A, Isermann B, Thiery J, Kaiser T (2021). Experiences from six years of quality assured Model of End Stage Liver Disease (MELD) diagnostics. PLoS One, 16(8), 0254219.
     
  53. Ablefoni M, Surup H, Ehrengut C, Schindler A, Seehofer D, Denecke T, Meyer HJ (2021). Diagnostic Benefit of High b-Value Computed Diffusion-Weighted Imaging in Patients with Hepatic Metastasis. J Clin Med, 10(22), 5289.
     
  54. Heinrich S, Seehofer D, Corvinus F, Tripke V, Huber T, Hüttl F, Penzkofer L, Mittler J, Abu Hilal M, Lang H (2021). [Advantages and future perspectives of laparoscopic liver surgery]. Chirurg, 92(6), 542-549.
     
  55. Pfrepper C, Herber A, Weimann A, Siegemund R, Engelmann C, Aehling N, Seehofer D, Berg T, Petros S (2021). Safety and efficacy of direct oral anticoagulants under long-term immunosuppressive therapy after liver, kidney and pancreas transplantation. Transpl Int, 34(3), 423-435.
     
  56. Kurch L, Georgi TW, Monecke A, Seehofer D, Borte G, Sabri O, Kluge R, Heyn S, Pierer M, Platzbecker U, Kayser S (2021). Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report. Front Oncol, 11(), 798757.
     
  57. Lange UG, Rademacher S, Zirnstein B, Sucher R, Semmling K, Bobbert P, Lederer AA, Buchloh D, Seidemann L, Seehofer D, Jahn N, Hau HM (2021). Cardiovascular outcomes after simultaneous pancreas kidney transplantation compared to kidney transplantation alone: a propensity score matching analysis. BMC Nephrol, 22(1), 347.
     


    58. 2020


  58. Gockel I, Jansen-Winkeln B, Holfert N, Rayes N, Thieme R, Maktabi M, Sucher R, Seehofer D, Barberio M, Diana M, Rabe SM, Mehdorn M, Moulla Y, Niebisch S, Branzan D, Rehmet K, Takoh JP, Petersen TO, Neumuth T, Melzer A, Chalopin C, Kohler H (2020). [Possibilities and perspectives of hyperspectral imaging in visceral surgery]. Chirurg, 91(2), 150-159.
     
  59. Moulla Y, Petersen TO, Maiwald B, Bailis N, Kreuser N, Lordick F, Seehofer D, Sucher R, Hecker M, Hoffmeister A, Jansen-Winkeln B, Gockel I (2020). [Ablative treatment options for locally advanced unresectable and borderline resectable pancreatic carcinoma]. Chirurg, 91(4), 319-328.
     
  60. Gockel I, Jansen-Winkeln B, Sucher R, Rayes N, Thieme R, Moulla Y, Niebisch S, Rademacher S, Seehofer D, Schierle K, Bläker H, Neumuth T, Melzer A, Maktabi M, Köhler H, Chalopin C (2020). Hyperspektral-Imaging (HSI) ? eine verlässliche Gewebedifferenzierung? Zentralbl Chir, 145(2), 125-129.
     
  61. von Dercks N, Seehofer D, Steinert M, Krämer S, Branzan D, Dietrich A, Schürmann O, Gockel I (2020). [How severe is the effect of the coronavirus pandemic on the department of surgery of a university hospital? : An analysis of the first 7 weeks]. Chirurg, 91(9), 755-761.
     
  62. Hau HM, Meyer F, Jahn N, Rademacher S, Sucher R, Seehofer D (2020). Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma. J Clin Med, 9(10), 3152.
     
  63. Sucher R, Seehofer D (2020). ASO Author Reflections: Hepatobiliary Surgeons are Spurred to Implement Totally Minimally Invasive Techniques for Perihilar Cholangiocarcinoma Surgery. Ann Surg Oncol, (), 1-2.
     
  64. Sucher R, Scheuermann U, Seehofer D (2020). Total Laparoscopic Resection of Hilar Cholangiocarcinoma Type 3b: Applying a Parachute Technique for Hepaticojejunostomy. Ann Surg Oncol, (), 1-5.
     
  65. Scheuermann U, Rademacher S, Jahn N, Sucher E, Seehofer D, Sucher R, Hau HM (2020). Impact of pre-transplant dialysis modality on the outcome and health-related quality of life of patients after simultaneous pancreas-kidney transplantation. Health Qual Life Outcomes, 18(1), 303.
     
  66. Sucher R, Wagner T, Köhler H, Sucher E, Guice H, Recknagel S, Lederer A, Hau HM, Rademacher S, Schneeberger S, Brandacher G, Gockel I, Seehofer D (2020). Hyperspectral Imaging (HSI) of Human Kidney Allografts. Ann Surg, (), epub ahead .
     
  67. Sucher E, Sucher R, Geissler A, Guice H, Doss M, Gockel I, Seehofer D, Branzan D (2020). Decompression surgery of the celiac trunc?a single center experience Laparoscopic Surgery, 4 (25), 1-8.
     
  68. Sucher R, Brunotte M, Seehofer D (2020). [Indocyanine green fluorescence staining in liver surgery]. Chirurg, 91(6), 466-473.
     
  69. Brunotte M, Rademacher S, Weber J, Sucher E, Lederer A, Hau HM, Stolzenburg JU, Seehofer D, Sucher R (2020). Robotic assisted nephrectomy for living kidney donation (RANLD) with use of multiple locking clips or ligatures for renal vascular closure. Ann Transl Med, 8(6), 305.
     
  70. Hau HM, Jahn N, Brunotte M, Lederer AA, Sucher E, Rasche FM, Seehofer D, Sucher R (2020). Short and long-term metabolic outcomes in patients with type 1 and type 2 diabetes receiving a simultaneous pancreas kidney allograft. BMC Endocr Disord, 20(1), 30.
     
  71. Atanasov G, Dino K, Schierle K, Dietel C, Aust G, Pratschke J, Seehofer D, Schmelzle M, Hau HM (2020). Recipient Hepatic Tumor-Associated Immunologic Infiltrates Predict Outcomes After Liver Transplantation for Hepatocellular Carcinoma. Ann Transplant, 25(), e919414.
     
  72. Rennert C, Heil T, Schicht G, Stilkerich A, Seidemann L, Kegel-Hübner V, Seehofer D, Damm G (2020). Prolonged Lipid Accumulation in Cultured Primary Human Hepatocytes Rather Leads to ER Stress than Oxidative Stress. Int J Mol Sci, 21(19), 7097.
     
  73. Sucher R, Rademacher S, Lederer A, Hau HM, Petersen TO, Seehofer D (2020). [Laparoscopic Left Hemihepatectoy Applying Intraoperative Indocyanine Green Fluorescence Detection Counter Perfusion Method for Visualization]. Zentralbl Chir, 145(2), 135-137.
     
  74. Kok F, Rosenblatt M, Teusel M, Nizharadze T, Gonçalves Magalhães V, Dächert C, Maiwald T, Vlasov A, Wäsch M, Tyufekchieva S, Hoffmann K, Damm G, Seehofer D, Boettler T, Binder M, Timmer J, Schilling M, Klingmüller U (2020). Disentangling molecular mechanisms regulating sensitization of interferon alpha signal transduction. Mol Syst Biol, 16(7), 8955.
     
  75. Robichon K, Maiwald T, Schilling M, Schneider A, Willemsen J, Salopiata F, Teusel M, Kreutz C, Ehlting C, Huang J, Chakraborty S, Huang X, Damm G, Seehofer D, Lang PA, Bode JG, Binder M, Bartenschlager R, Timmer J, Klingmüller U (2020). Identification of Interleukin1? as an Amplifier of Interferon alpha-induced Antiviral Responses. PLoS Pathog, 16(10), 1008461.
     
  76. Aehling NF, Seehofer D, Berg T (2020). [Liver transplantation - current trends]. Dtsch Med Wochenschr, 145(16), 1124-1131.
     
  77. Auer TA, Fehrenbach U, Grieser C, Penzkofer T, Geisel D, Schmelzle M, Müller T, Bläker H, Seehofer D, Denecke T (2020). Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Eur Radiol, 30(6), 3497-3506.
     
  78. Heinemann ML, Elsing L, Kaiser T, Boettcher M, Herber A, Seehofer D, Berg T, Ceglarek U (2020). Challenges of LC-MS/MS ethyl glucuronide analysis in abstinence monitoring of liver transplant candidates. Clin Chem Lab Med, 58(8), 1265-1270.
     
  79. Modest DP, Heinemann V, Folprecht G, Denecke T, Pratschke J, Lang H, Bemelmans M, Becker T, Rentsch M, Seehofer D, Bruns CJ, Gebauer B, Held S, Stahler A, Heinrich K, von Einem JC, Stintzing S, Neumann UP, Ricard I (2020). Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306. Ann Surg Oncol, 27(7), 2389-2401.
     


    80. 2019


  80. Sucher R, Athanasios A, Kohler H, Wagner T, Brunotte M, Lederer A, Gockel I, Seehofer D (2019). Hyperspectral Imaging (HSI) in anatomic left liver resection. Int J Surg Case Rep, 62, 108-111.
     
  81. Atanasov G, Dino K, Schierle K, Dietel C, Aust G, Pratschke J, Seehofer D, Schmelzle M, Hau HM (2019). Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis. World J Surg Oncol, 17(1), 217-.
     
  82. Atanasov G, Dino K, Schierle K, Dietel C, Aust G, Pratschke J, Seehofer D, Schmelzle M, Hau HM (2019). Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes. World J Surg Oncol, 17(1), 97-.
     
  83. Damm G, Schicht G, Zimmermann A, Rennert C, Fischer N, Kiessig M, Wagner T, Kegel V, Seehofer D (2019). Effect of glucose and insulin supplementation on the isolation of primary human hepatocytes. EXCLI J, 18, 1071-1091.
     
  84. Ruoss M, Damm G, Vosough M, Ehret L, Grom-Baumgarten C, Petkov M, Naddalin S, Ladurner R, Seehofer D, Nussler A, Sajadian S (2019). Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity. Int J Mol Sci, 20(2), 1071-1091.
     
  85. Sucher R, Rademacher S, Jahn N, Brunotte M, Wagner T, Alvanos A, Sucher E, Seehofer D, Scheuermann U, Hau HM (2019). Effects of simultaneous pancreas-kidney transplantation and kidney transplantation alone on the outcome of peripheral vascular diseases. BMC Nephrol, 20(1), 453.
     
  86. Sucher R, Hau HM, Rademacher S, Lederer A, Petersen TO, Seehofer D (2019). Totally Minimally Invasive Extended Right Hepatectomy Using the Intracorporal Liver Hanging Maneuver Videoscopy, 29(4), 576.
     
  87. Freyer N, Knospel F, Damm G, Greuel S, Schneider C, Seehofer D, Stohr T, Petersen KU, Zeilinger K (2019). Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug Des Devel Ther, 13, 1033-1047.
     
  88. Albrecht W, Kappenberg F, Brecklinghaus T, Stoeber R, Marchan R, Zhang M, Ebbert K, Kirschner H, Grinberg M, Leist M, Moritz W, Cadenas C, Ghallab A, Reinders J, Vartak N, van Thriel C, Golka K, Tolosa L, Castell JV, Damm G, Seehofer D, Lampen A, Braeuning A, Buhrke T, Behr AC, Oberemm A, Gu X, Kittana N, van de Water B, Kreiling R, Fayyaz S, van Aerts L, Smedsrod B, Ellinger-Ziegelbauer H, Steger-Hartmann T, Gundert-Remy U, Zeigerer A, Ullrich A, Runge D, Lee SML, Schiergens TS, Kuepfer L, Agua (2019). Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations. Arch Toxicol, 93(6), 1609-1637.
     
  89. Kolbe E, Aleithe S, Rennert C, Spormann L, Ott F, Meierhofer D, Gajowski R, Stopel C, Hoehme S, Kucken M, Brusch L, Seifert M, von Schoenfels W, Schafmayer C, Brosch M, Hofmann U, Damm G, Seehofer D, Hampe J, Gebhardt R, Matz-Soja M (2019). Mutual Zonated Interactions of Wnt and Hh Signaling Are Orchestrating the Metabolism of the Adult Liver in Mice and Human. Cell Rep, 29(13), 4553-4567.
     
  90. Karlas T, Reinhardt F, Blank V, Lippmann N, Seehofer D, Lubbert C (2019). Frequency and clinical presentation of alveolar and cystic echinococcosis in a tertiary medical center in Germany 2004-2018: lessons from a low-prevalence area. Z Gastroenterol, 57(11), 1281-1290.
     
  91. Trawinski H, Karlas T, Seehofer D, Lubbert C, Halbritter J (2019). The Case | Atypical cysts in a patient with autosomal dominant polycystic kidney disease. Kidney Int, 96(4), 1043-1044.
     
  92. Herta T, Petroff D, Engelmann C, Herber A, Aehling N, Scheuermann U, Bartels M, Seehofer D, Berg T, Wiegand J (2019). Hepatitis B Vaccination in Patients with Liver Cirrhosis Evaluated for Liver Transplantation - A Simple Intervention Ensures High Adherence. Ann Transplant, 24, 527-531.
     
  93. Albrecht W, Kappenberg F, Brecklinghaus T, Stoeber R, Marchan R, Zhang M, Ebbert K, Kirschner H, Grinberg M, Leist M, Moritz W, Cadenas C, Ghallab A, Reinders J, Vartak N, van Thriel C, Golka K, Tolosa L, Castell JV, Damm G, Seehofer D, Lampen A, Braeuning A, Buhrke T, Behr AC, Oberemm A, Gu X, Kittana N, van de Water B, Kreiling R, Fayyaz S, van Aerts L, Smedsrod B, Ellinger-Ziegelbauer H, Steger-Hartmann T, Gundert-Remy U, Zeigerer A, Ullrich A, Runge D, Lee SML, Schiergens TS, Kuepfer L, Agua (2019). Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations. Arch Toxicol, 93(6), 1609-1637.
     
  94. Schneider C, Remmler J, Netto J, Seehofer D, Engelmann C, Berg T, Thiery J, Kaiser T (2019). Copeptin - a biomarker of short-term mortality risk (7 days) in patients with end-stage liver disease. Clin Chem Lab Med, 57(12), 1897-1905.
     
  95. Ottlewski I, Munch J, Wagner T, Schonauer R, Bachmann A, Weimann A, Hentschel J, Lindner TH, Seehofer D, Bergmann C, Jamra RA, Halbritter J (2019). Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease. Kidney Int, 96(1), 222-230.
     
  96. Theilig D, Steffen I, Malinowski M, Stockmann M, Seehofer D, Pratschke J, Hamm B, Denecke T, Geisel D (2019). Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI. Eur Radiol, 29(11), 5861-5872.
     
  97. Wiltberger G, Wu Y, Lange U, Hau HM, Tapper E, Krenzien F, Atanasov G, Benzing C, Feldbrugge L, Csizmadia E, Broschewitz J, Bartels M, Seehofer D, Jonas S, Berg T, Hessel P, Ascherl R, Neumann UP, Pratschke J, Robson SC, Schmelzle M (2019). Protective effects of coffee consumption following liver transplantation for hepatocellular carcinoma in cirrhosis. Aliment Pharmacol Ther, 49(6), 779-788.
     
  98. Engelmann C, Schob S, Seehofer D, Berg T (2019). Editorial: moving towards a robust definition of sarcopenia in cirrhosis-authors' reply. Aliment Pharmacol Ther, 49(3), 341-342.
     


    99. 2018


  99. Modest DP, Denecke T, Pratschke J, Ricard I, Lang H, Bemelmans M, Becker T, Rentsch M, Seehofer D, Bruns CJ, Gebauer B, Modest HI, Held S, Folprecht G, Heinemann V, Neumann UP (2018). Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3. Eur J Cancer, 88, 77-86.
     
  100. Lucarelli P, Schilling M, Kreutz C, Vlasov A, Boehm ME, Iwamoto N, Steiert B, Lattermann S, Wasch M, Stepath M, Matter MS, Heikenwalder M, Hoffmann K, Deharde D, Damm G, Seehofer D, Muciek M, Gretz N, (2018). Resolving the Combinatorial Complexity of Smad Protein Complex Formation and Its Link to Gene Expression. Cell Syst, 6, 75-89.
     
  101. Freyer N, Greuel S, Knospel F, Gerstmann F, Storch L, Damm G, Seehofer D, Foster Harris J, Iyer R, Schubert F, Zeilinger K (2018). Microscale 3D Liver Bioreactor for In Vitro Hepatotoxicity Testing under Perfusion Conditions. Bioengineering (Basel), 5, 1-18.
     
  102. Brosch M, Kattler K, Herrmann A, von Schonfels W, Nordstrom K, Seehofer D, Damm G, Becker T, Zeissig S, Nehring S, Reichel F, Moser V, Thangapandi RV, Stickel F, Baretton G, Rocken C, Muders M, Matz-S (2018). Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic control. Nat Commun, 9, 1-11.
     
  103. Engelmann C, Schob S, Nonnenmacher I, Werlich L, Aehling N, Ullrich S, Kaiser T, Krohn S, Herber A, Sucher R, Bartels M, Surov A, Hasenclever D, Kahn T, Seehofer D, Moche M, Berg T (2018). Loss of paraspinal muscle mass is a gender-specific consequence of cirrhosis that predicts complications and death. Aliment Pharmacol Ther, 48, 1271-1281.
     
  104. Schlottau K, Forth L, Angstwurm K, Hoper D, Zecher D, Liesche F, Hoffmann B, Kegel V, Seehofer D, Platen S, Salzberger B, Liebert UG, Niller HH, Schmidt B, Matiasek K, Riemenschneider MJ, Brochhausen (2018). Fatal Encephalitic Borna Disease Virus 1 in Solid-Organ Transplant Recipients. N Engl J Med, 379, 1377-1379.
     
  105. Heits N, Brosch M, Herrmann A, Behrens R, Rocken C, Schrem H, Kaltenborn A, Klempnauer J, Kreipe HH, Reichert B, Lenschow C, Wilms C, Vogel T, Wolters H, Wardelmann E, Seehofer D, Buch S, Zeissig S, P (2018). Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular Carcinoma. Transplantation, 102, 424-430.
     
  106. Modest DP, Denecke T, Pratschke J, Ricard I, Lang H, Bemelmans M, Becker T, Rentsch M, Seehofer D, Bruns CJ, Gebauer B, Modest HI, Held S, Folprecht G, Heinemann V, Neumann UP (2018). Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3. Eur J Cancer, 88, 77-86.
     
  107. Berg T, Seehofer D, Kaiser T (2018). Reply. Clin Gastroenterol Hepatol, 16, 783-784.
     


    108. 2017


  108. Hau HM, Kloss A, Wiltberger G, Jahn N, Krenzien F, Benzing C, Schmelzle M, Seehofer D, Atanasov G, Bartels M (2017). The challenge of liver resection in benign solid liver tumors in modern times - in which cases should surgery be done? Z Gastroenterol, 55(7), 639-652.
     
  109. Rademacher S, Seehofer D, Eurich D, Schoening W, Neuhaus R, Oellinger R, Denecke T, Pascher A, Schott E, Sinn M, Neuhaus P, Pratschke J (2017). The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients. Liver Transpl, 23(11), 1404-1414.
     
  110. Seehofer D, Sucher R, Schmelzle M, Ollinger R, Lederer A, Denecke T, Schott E, Pratschke J (2017). Evolution of laparoscopic liver surgery as standard procedure for HCC in cirrhosis? Z Gastroenterol, 55(5), 453-460.
     
  111. Seehofer D, Ollinger R, Denecke T, Schmelzle M, Andreou A, Schott E, Pratschke J (2017). Blood Transfusions and Tumor Biopsy May Increase HCC Recurrence Rates after Liver Transplantation. J Transplant, 2017, 9731095.
     
  112. Schmidt-Heck W, Wonne EC, Hiller T, Menzel U, Koczan D, Damm G, Seehofer D, Knospel F, Freyer N, Guthke R, Dooley S, Zeilinger K (2017). Global Transcriptional Response of Human Liver Cells to Ethanol Stress of Different Strength Reveals Hormetic Behavior. Alcohol Clin Exp Res, 41(5), 883-894.
     
  113. Mleczko-Sanecka K, da Silva AR, Call D, Neves J, Schmeer N, Damm G, Seehofer D, Muckenthaler MU (2017). Imatinib and spironolactone suppress hepcidin expression. Haematologica, 102(7), 1173-1184.
     
  114. Camp JG, Sekine K, Gerber T, Loeffler-Wirth H, Binder H, Gac M, Kanton S, Kageyama J, Damm G, Seehofer D, Belicova L, Bickle M, Barsacchi R, Okuda R, Yoshizawa E, Kimura M, Ayabe H, Taniguchi H, Takeb (2017). Multilineage communication regulates human liver bud development from pluripotency. Nature, 546(7659), 533-538.
     
  115. Wallstab C, Eleftheriadou D, Schulz T, Damm G, Seehofer D, Borlak J, Holzhutter HG, Berndt N (2017). A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis. FEBS J, 284(19), 3245-3261.
     
  116. Sobotta S, Raue A, Huang X, Vanlier J, Junger A, Bohl S, Albrecht U, Hahnel MJ, Wolf S, Mueller NS, D Alessandro LA, Mueller-Bohl S, Boehm ME, Lucarelli P, Bonefas S, Damm G, Seehofer D, Lehmann WD, R (2017). Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor Ruxolitinib. Front Physiol, 8, 775.
     
  117. Stockmann M, Bednarsch J, Malinowski M, Bluthner E, Pratschke J, Seehofer D, Jara M (2017). Functional considerations in ALPPS - consequences for clinical management. HPB (Oxford), 19(11), 1016-1025.
     
  118. Schlegel V, Treuner-Kaueroff T, Seehofer D, Berg T, Becker S, Ceglarek U, Thiery J, Kaiser T (2017). Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease. PLoS One, 12(7), e0181540.
     
  119. Becker S, Kinny-Koster B, Bartels M, Scholz M, Seehofer D, Berg T, Engelmann C, Thiery J, Ceglarek U, Kaiser T (2017). Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis. PLoS One, 12(3), e0174424.
     
  120. Geisel D, Raabe P, Ludemann L, Malinowski M, Stockmann M, Seehofer D, Pratschke J, Hamm B, Denecke T (2017). Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial. Eur Radiol, 27(7), 3080-3087.
     


    121. 2016


  121. Kegel V, Deharde D, Pfeiffer E, Zeilinger K, Seehofer D, Damm G (2016). Protocol for Isolation of Primary Human Hepatocytes and Corresponding Major Populations of Non-parenchymal Liver Cells. J Vis Exp, 109, e53069.
     
  122. Deharde D, Schneider C, Hiller T, Fischer N, Kegel V, Lubberstedt M, Freyer N, Hengstler JG, Andersson TB, Seehofer D, Pratschke J, Zeilinger K, Damm G (2016). Bile canaliculi formation and biliary transport in 3D sandwich-cultured hepatocytes in dependence of the extracellular matrix composition. Arch Toxicol, 90(10), 2497-2511.
     
  123. Eurich D, Henze S, Boas-Knoop S, Pratschke J, Seehofer D (2016). T-drain reduces the incidence of biliary leakage after liver resection. Updates Surg, 68(4), 369-376.
     
  124. Schoening W, Buescher N, Neidel N, Helbig M, Andreou A, Pascher A, Bahra M, Pratschke J, Seehofer D (2016). Cerebrovascular events in 20 years of follow-up after liver transplantation: an underestimated issue? Clin Transplant, 30(10), 1276-1282.
     
  125. Andreou A, Bahra M, Schmelzle M, Ollinger R, Sucher R, Sauer IM, Guel-Klein S, Struecker B, Eurich D, Klein F, Pascher A, Pratschke J, Seehofer D (2016). Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation. Clin Transplant, 30(7), 819-827.
     
  126. Schoening WN, Helbig M, Buescher N, Andreou A, Bahra M, Schmitz V, Pascher A, Pratschke J, Seehofer D (2016). Gender Matches in Liver Transplant Allocation: Matched and Mismatched Male-Female Donor-Recipient Combinations; Long-term Follow-up of More Than 2000 Patients at a Single Center. Exp Clin Transplant, 14(2), 184-190.
     
  127. Schoening W, Helbig M, Buescher N, Andreou A, Schmitz V, Bahra M, Puhl G, Pascher A, Pratschke J, Seehofer D (2016). Eurotransplant donor-risk-index and recipient factors: influence on long-term outcome after liver transplantation - A large single-center experience. Clin Transplant, 30(5), 508-517.
     
  128. Struecker B, Andreou A, Sauer IM, Pratschke J, Seehofer D (2016). Risk factors for bile leakage after hepatectomy. Hepatobiliary Pancreat Dis Int, 15(1), 12-13.
     
  129. Freyer N, Knospel F, Strahl N, Amini L, Schrade P, Bachmann S, Damm G, Seehofer D, Jacobs F, Monshouwer M, Zeilinger K (2016). Hepatic Differentiation of Human Induced Pluripotent Stem Cells in a Perfused Three-Dimensional Multicompartment Bioreactor. Biores Open Access, 5(1), 235-248.
     
  130. Godoy P, Widera A, Schmidt-Heck W, Campos G, Meyer C, Cadenas C, Reif R, Stober R, Hammad S, Putter L, Gianmoena K, Marchan R, Ghallab A, Edlund K, Nussler A, Thasler WE, Damm G, Seehofer D, Weiss TS, (2016). Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue. Arch Toxicol, 90(10), 2513-2529.
     
  131. Schmelzle M, Sucher R, Seehofer D, Pratschke J (2016). Regarding: Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma. Surgery, 159(3), 986-987.
     
  132. Herzog N, Hansen M, Miethbauer S, Schmidtke KU, Anderer U, Lupp A, Sperling S, Seehofer D, Damm G, Scheibner K, Kupper JH (2016). Primary-like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures. Cell Biol Int, 40(3), 341-353.
     
  133. Iwamoto N, D Alessandro LA, Depner S, Hahn B, Kramer BA, Lucarelli P, Vlasov A, Stepath M, Bohm ME, Deharde D, Damm G, Seehofer D, Lehmann WD, Klingmuller U, Schilling M (2016). Context-specific flow through the MEK/ERK module produces cell- and ligand-specific patterns of ERK single and double phosphorylation. Sci Signal, 9(413), 13.
     
  134. Kandel BA, Thomas M, Winter S, Damm G, Seehofer D, Burk O, Schwab M, Zanger UM (2016). Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPAR? in primary human hepatocytes. Biochim Biophys Acta, 1859(9), 1218-1227.
     
  135. Knöspel F, Jacobs F, Freyer N, Damm G, De Bondt A, van den Wyngaert I, Snoeys J, Monshouwer M, Richter M, Strahl N, Seehofer D, Zeilinger K (2016). In Vitro Model for Hepatotoxicity Studies Based on Primary Human Hepatocyte Cultivation in a Perfused 3D Bioreactor System. Int J Mol Sci, 17(4), 584.
     
  136. Zeilinger K, Freyer N, Damm G, Seehofer D, Knospel F (2016). Cell sources for in vitro human liver cell culture models. Exp Biol Med (Maywood), 241(15), 1684-1698.
     
  137. Kurth F, Lingscheid T, Steiner F, Stegemann MS, Belard S, Menner N, Pongratz P, Kim J, von Bernuth H, Mayer B, Damm G, Seehofer D, Salama A, Suttorp N, Zoller T (2016). Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria. Emerg Infect Dis, 22(8), 1381-1386.
     
  138. Buescher N, Seehofer D, Helbig M, Andreou A, Bahra M, Pascher A, Pratschke J, Schoening W (2016). Evaluating twenty-years of follow-up after orthotopic liver transplantation, best practice for donor-recipient matching: What can we learn from the past era? World J Transplant, 6(3), 599-607.
     
  139. Mantel HT, Westerkamp AC, Adam R, Bennet WF, Seehofer D, Settmacher U, Sanchez-Bueno F, Fabregat Prous J, Boleslawski E, Friman S, Porte RJ (2016). Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival. PLoS One, 11(6), e0156127.
     
  140. Bednarsch J, Bluthner E, Malinowski M, Seehofer D, Pratschke J, Stockmann M (2016). Regeneration of Liver Function Capacity After Partial Liver Resection is Impaired in Case of Postoperative Bile Leakage. World J Surg, 40(9), 2221-2228.
     
  141. Andreou A, Biebl M, Dadras M, Struecker B, Sauer IM, Thuss-Patience PC, Chopra S, Fikatas P, Bahra M, Seehofer D, Pratschke J, Schmidt SC (2016). Anastomotic leak predicts diminished long-term survival after resection for gastric and esophageal cancer. Surgery, 160(1), 191-203.
     
  142. Malinowski M, Lock JF, Seehofer D, Gebauer B, Schulz A, Demirel L, Bednarsch J, Stary V, Neuhaus P, Stockmann M (2016). Preliminary study on liver function changes after trisectionectomy with versus without prior portal vein embolization. Surg Today, 46(9), 1053-1061.
     
  143. Olschewski P, Seehofer D, Ollinger R, Pratschke J (2016). [Vascular reconstruction in visceral transplantation surgery]. Chirurg, 87(2), 114-118.
     


    144. 2015


  144. Benzing C, Krenzien F, Atanasov G, Seehofer D, Sucher R, Zorron R, Pratschke J, Schmelzle M (2015). Single incision laparoscopic liver resection (SILL) - a systematic review. GMS Interdiscip Plast Reconstr Surg DGPW, 4, doc17.
     
  145. Raschzok N, Reutzel-Selke A, Schmuck RB, Morgul MH, Gauger U, Prabowo KA, Tannus LM, Leder A, Struecker B, Boas-Knoop S, Bartels M, Jonas S, Lojewski C, Puhl G, Seehofer D, Bahra M, Pascher A, Pratsch (2015). CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation. Liver Transpl, 21(9), 1195-1207.
     


    146. 2012


  146. Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, Seehofer D (2012). Oncological Superiority of Hilar En Bloc Resection for the Treatment of Hilar Cholangiocarcinoma. Ann Surg Oncol, 19(5), 1602-8.
     


    147. 2009


  147. Seehofer D, Thelen A, Neumann UP, Veltzke-Schlieker W, Denecke T, Kamphues C, Pratschke J, Jonas S, Neuhaus P (2009). Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver Transpl, 15(11), 1499-1507.
     
  148. Neumann UP, Thelen A, Rocken C, Seehofer D, Bahra M, Riess H, Jonas S, Schmeding M, Pratschke J, Bova R, Neuhaus P (2009). Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases. Surgery, 146(1), 52-59.